Fact CheckerSign in

NCT06230783Recruiting

Speech Pattern Evaluation and Analysis for Knowledge of AD

Connected Language and Speech Along the Spectrum of ADRD: Digital Assessment and Monitoring

Source: ClinicalTrials.gov · Last updated 12 Mar 2026

Brief summary (registry, in English)

The goal of this observational study is to validate changes in speech as a measure of cognition in individuals at increased risk of Alzheimer's disease and related dementias (ADRD). This study aims to clarify how speech may be affected by Alzheimer's disease. Participants will complete speech collection sessions and a survey at home using an iPad. Participants can expect to be in the study for 3 years.

Status (registry)
Recruiting
Study type
Observational
Enrollment
165 (estimated)
First submitted
19 Jan 2024
Start date
22 Jan 2025
Primary completion date
Feb 2029
Lead sponsor
University of Wisconsin, Madison
NCT number
NCT06230783

What you commit to

  • Study type: Observational
  • Planned participants: 165
  • From 22 Jan 2025 to the primary completion date, Feb 2029
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Diagnosis of dementia
  • Major neurological conditions
  • Speech disorders

Other

  • Not actively enrolled in W-ADRC or WRAP
  • Impaired capacity or unwilling to consent

Who the study is looking for

  • Must be enrolled in the Wisconsin Alzheimer's Disease Research Center (W-ADRC) Clinical Core or IMPACT studies, or in the Wisconsin Registry for Alzheimer's Prevention (WRAP)
  • Cognitively unimpaired or have a diagnosis of Mild Cognitive Impairment (MCI)
  • Ages 40-80 years
  • Completion of a W-ADRC or WRAP study visit within the past or upcoming 12 months
  • Have provided W-ADRC or WRAP with blood plasma Alzheimer's Disease

Age in the registry: 40 years to 80 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Wisconsin
Coordinator of this site? Confirm its status
MadisonUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.